Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

Introduction The integration of artificial intelligence (AI) into healthcare introduces innovative possibilities but raises ethical, legal and professional concerns. Assessing the performance of AI in ...

The trend towards postponement of childbearing has seen increasing numbers of women turning towards oocyte banking for anticipated gamete exhaustion (AGE banking), which offers a realistic chance of ...

What Is a Person: Untapped Insights from Africa, a new book by Nancy Jecker and Caesar Atuire, offers an appealing and fresh perspective into ongoing debates surrounding personhood.1 The bioethics ...

The first theme that emerges from the commentaries has to do with dignity. In the article, I did not suggest a grounds for dignity based on a life force ethic. Instead, I focused on describing the ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

When the clinician and patient are unable to reconcile differences over treatment, does this mean the latter lacks capacity to decide in such matters? Wellesley et al analyse the legal judgements in ...

Medical ethics and law (MEL) have a well-established place in medical curricula within the UK, but appropriately assessing MEL in a medical school context can be extremely challenging. The Institute ...

UK doctors’ strikes 2023–2024: still justified in the interests of public health, even in time-critical outpatient contexts (13 July, 2024) ...

The Roman Catholic Church in Australia has lobbied politicians to prohibit embryonic stem cell research, on the grounds that such research violates the sanctity and inherent dignity of human life. I ...

Correspondence to Dr Cristina Richie, Philosophy and Ethics of Technology, Technische Universiteit Delft, Delft 2628, The Netherlands; c.s.richie{at}tudelft.nl The US healthcare industry emits an ...